FIXX ALERT: Hagens Berman, National Trial Attorneys, Encourages Investors in Homology Medicines (FIXX) with Significant Losses to Contact Firm, Securities Fraud Class Action Filed
April 04, 2022 15:26 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Homology Medicines, Inc. (NASDAQ: FIXX) investors who suffered significant losses to submit your losses now. A securities fraud...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Homology Medicines (FIXX) Investors with Losses to Contact Its Attorneys, Firm Investigating Possible Securities Fraud
November 10, 2020 15:05 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges Homology Medicines, Inc. (NASDAQ: FIXX) investors with significant losses to submit your losses now. The firm is investigating...
FIXX SHAREHOLDER ALERT: Hagens Berman, National Trial Attorneys, Encourages Homology Medicines (FIXX) Investors with Losses to Contact Its Attorneys, Firm Investigating Possible Securities Fraud
October 14, 2020 17:28 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges Homology Medicines, Inc. (NASDAQ: FIXX) investors with significant losses to submit your losses now. The firm is investigating...